RhumbLine Advisers’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
27,341
+3,047
| +13% | +$128K | ﹤0.01% | 2176 |
|
|
2025
Q1 | $920K | Buy |
24,294
+1,525
| +7% | +$57.8K | ﹤0.01% | 2215 |
|
|
2024
Q4 | $1.75M | Sell |
22,769
-347
| -2% | -$26.7K | ﹤0.01% | 1957 |
|
|
2024
Q3 | $1.33M | Buy |
23,116
+924
| +4% | +$53.2K | ﹤0.01% | 2115 |
|
|
2024
Q2 | $918K | Buy |
22,192
+22,040
| +14,500% | +$912K | ﹤0.01% | 2300 |
|
|
2024
Q1 | $9.28K | Hold |
152
| – | – | ﹤0.01% | 3882 |
|
|
2023
Q4 | $3.39K | Hold |
152
| – | – | ﹤0.01% | 4040 |
|
|
2023
Q3 | $3.91K | Sell |
152
-88
| -37% | -$2.26K | ﹤0.01% | 4022 |
|
|
2023
Q2 | $4.14K | Sell |
240
-3,984
| -94% | -$68.7K | ﹤0.01% | 4120 |
|
|
2023
Q1 | $51K | Buy |
4,224
+527
| +14% | +$6.36K | ﹤0.01% | 2906 |
|
|
2022
Q4 | $132K | Buy |
3,697
+18
| +0.5% | +$643 | ﹤0.01% | 2866 |
|
|
2022
Q3 | $125K | Buy |
3,679
+448
| +14% | +$15.2K | ﹤0.01% | 2979 |
|
|
2022
Q2 | $119K | Buy |
3,231
+473
| +17% | +$17.4K | ﹤0.01% | 3018 |
|
|
2022
Q1 | $422K | Buy |
2,758
+231
| +9% | +$35.3K | ﹤0.01% | 2496 |
|
|
2021
Q4 | $747K | Buy |
2,527
+151
| +6% | +$44.6K | ﹤0.01% | 2335 |
|
|
2021
Q3 | $659K | Buy |
2,376
+438
| +23% | +$121K | ﹤0.01% | 2426 |
|
|
2021
Q2 | $531K | Buy |
1,938
+1,232
| +175% | +$338K | ﹤0.01% | 2537 |
|
|
2021
Q1 | $347K | Buy |
706
+34
| +5% | +$16.7K | ﹤0.01% | 2646 |
|
|
2020
Q4 | $555K | Buy |
+672
| New | +$555K | ﹤0.01% | 2400 |
|